Skip to content

Public FDA record

Z-1866-2017: BD Viper LT software, version 3.00H

Recall record Z-1866-2017 for Bd Diagnostic. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1866-2017
Company in FDA record
Bd Diagnostic
FDA classification date
Apr 4, 2017
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

BD has confirmed reports that lower than expected RFU values were generated on customer BD Viper LT Systems after the installation of software version 3.00H. As RFU values decrease, results approach the assay cutoff threshold which has the potential to impact test results.

Source facts

Action
Recall action was initiated on December 14, 2015 when software version 3.00H was removed from the two customer instruments. The 2 affected US customers were contacted via email and were also mailed a letter via UPS overnight express.
Initiated
2015-12-14
Root cause
Software design
Terminated
2017-04-19
Distribution
2 US customers, 0 Ex-US regions, and 0 distributors 0.
Recall number
Z-1866-2017
Recall status
Terminated
CDRH record ID
154526
FDA classified
2017-04-04
Recall event number
76895

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗